ConductScience.org, home

Gene · 5891

Papers1,940

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

101 to 120 of 1,940

Download this page as JSON
TitleJournalYearPMIDFound bySource
Targeting inflammatory and insulin-regulatory proteins in type 2 diabetes mellitus: Insights from Argemone ochroleuca (sweet) via multi-omics and network pharmacology with experimental verification.Int J Biol Macromol202540946985PubTator, text miningPubMed
β-Sitosterol as an Anti-Tumour Active Component of Herba Sarcandrae Inhibits Colorectal Cancer Progression Through Up-Regulation of TBX20.J Cell Mol Med202540889204PubTator, text miningPubMed
The identification of metabolites from gut microbiota in autism spectrum disorder via network pharmacology.Sci Rep202540877409PubTator, text miningPubMed
The Role of Extracellular Vesicles in Mediating Signaling in Biliary Epithelial Cell Activation and Cholangiopathies.Cells202540862753PubTator, text miningPubMed
Environmental exposure to perfluorooctane sulfonate and its role in esophageal cancer progression: a comprehensive bioinformatics and experimental study.Sci Rep202540858661PubTator, text miningPubMed
Identification and validation of oxidative stress signature genes in the trabecular meshwork of glaucoma.Sci Rep202540855175PubTator, text miningPubMed
Neutrophils-astrocyte interactions in central nervous system inflammation.Cell Death Dis202540854886PubTator, text miningPubMed
Immune and Vascular Function in Cardiometabolic Disorders: Interplay With Sex Differences and Impact on Incretin Therapy.Acta Physiol (Oxf)202540838278PubTator, text miningPubMed
Bioinspired porous core-shell microspheres with spatiotemporal delivery coordinate immunomodulatory-osteogenic coupling via NF-κB/P-STAT6 and Rho/MAPK signaling for enhanced calvarial regeneration.Bioact Mater202540831710PubTator, text miningPubMed
Eukaryotic initiation factors: central factor associating mRNA translational plasticity during neuropathic pain progression.Front Neurol202540823305PubTator, text miningPubMed
Network pharmacology and untargeted metabolomics reveal the mechanisms of Bushen Kaixuan Tongluo formula in diabetic kidney disease.J Chromatogr B Analyt Technol Biomed Life Sci202540818183PubTator, text miningPubMed
Understanding and targeting senescence in kidney disease.Clin Kidney J202540761301PubTator, text miningPubMed
Vitamin D immune modulation of the anti-inflammatory effects of HDL-associated proteins.Lipids Health Dis202540745557PubTator, text miningPubMed
Extracellular vesicles from bronchoalveolar lavage fluid provide insights into the inhaled corticosteroids treatment response in COPD.Respir Res202540739568PubTator, text miningPubMed
Network Pharmacology-Driven Sustainability: AI and Multi-Omics Synergy for Drug Discovery in Traditional Chinese Medicine.Pharmaceuticals (Basel)202540732361PubTator, text miningPubMed
High-mobility group box 1 in acute kidney injury.Front Pharmacol202540727103PubTator, text miningPubMed
Potential active ingredients and mechanisms of Shufeitie ointment in the treatment of chronic obstructive pulmonary disease by integrating transdermal chemistry and network pharmacology.Front Med (Lausanne)202540697927PubTator, text miningPubMed
Primary rupture law of main roof in long-wall face based on principal bending moment.Sci Rep202540646118PubTator, text miningPubMed
Future Perspectives and Conclusions from Animal Models of CHI3L1-Related Inflammation-Associated Cancer.Cells202540643503PubTator, text miningPubMed
The chemical-pharmacological continuum of Yucan formula: Integrated component-tissue exposure correlation informs diabetic kidney disease target network.J Chromatogr B Analyt Technol Biomed Life Sci202540609400PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/5891/papers?page=6